NRx Pharmaceuticals (NRXP) Announces Data Safety Monitoring

NRx Pharmaceuticals (NRXP) Announces Data Safety Monitoring Board Recommends to Stop Further Randomization in ACTIV-3b Trial of aviptadil

NRx Pharmaceuticals (NRXP) Announces Data Safety Monitoring Board Recommends to Stop Further Randomization in ACTIV-3b Trial of aviptadil

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Robert Besthof , National Institute Of Allergy , National Institutes Of Health , Nrx Pharmaceuticals Inc , Nrx Pharmaceuticals , Nasdaq , Wall Street , Data Safety , Monitoring Board , National Institute , Infectious Diseases , National Institutes , Trial Leadership , Breakthrough Therapy , Sub Acute Suicidal Ideation , Severe Bipolar Depression , Acute Suicidal Ideation ,